{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:25:10Z","timestamp":1773887110432,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"DBT OSRP","award":["PR6303"],"award-info":[{"award-number":["PR6303"]}]},{"DOI":"10.13039\/501100001407","name":"DBT","doi-asserted-by":"publisher","award":["PR13636"],"award-info":[{"award-number":["PR13636"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","award":["16H03279"],"award-info":[{"award-number":["16H03279"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LabEx ParaFrap"},{"name":"ERC Consolidator","award":["614880"],"award-info":[{"award-number":["614880"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP103258"],"award-info":[{"award-number":["OPP103258"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss National Foundation","award":["310030.146187\/1"],"award-info":[{"award-number":["310030.146187\/1"]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["090532\/Z\/09\/Z"],"award-info":[{"award-number":["090532\/Z\/09\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.str.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T14:45:50Z","timestamp":1504190750000},"page":"1495-1505.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Vitul","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manickam","family":"Yogavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiteru","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimitsu","family":"Hariguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastien","family":"Touquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv S.","family":"Jumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Tacchini-Cottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Harlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed-Ali","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2017.07.015_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib2","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth","volume":"57","author":"Bessoff","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/1471-2164-10-644","article-title":"A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum","volume":"10","author":"Bhatt","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.str.2017.07.015_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ncomms1522","article-title":"Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses","volume":"2","author":"Bhatt","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2017.07.015_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1087057112465980","article-title":"A spectrophotometric assay for quantitative measurement of aminoacyl-tRNA synthetase activity","volume":"18","author":"Cestari","year":"2013","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.str.2017.07.015_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-407705-8.00002-1","article-title":"A selective review of advances in coccidiosis research","volume":"83","author":"Chapman","year":"2013","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.str.2017.07.015_bib9","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s004360100402","article-title":"Chemotherapeutic approaches to protozoa: Coccidiae \u2013 current level of knowledge and outlook","volume":"87","author":"Greif","year":"2001","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.str.2017.07.015_bib11","doi-asserted-by":"crossref","first-page":"288ra277","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"Herman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.str.2017.07.015_bib12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.1952.1.768","article-title":"An antimalarial alkaloid from Hydrangea. XIII. The effects of various synthetic quinazolones against Plasmodium lophurae in ducks","volume":"1","author":"Hewitt","year":"1952","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.str.2017.07.015_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cbic.201200620","article-title":"Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum","volume":"14","author":"Hoen","year":"2013","journal-title":"ChemBioChem"},{"key":"10.1016\/j.str.2017.07.015_bib14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.str.2017.07.015_bib15","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.02220-13","article-title":"Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases","volume":"59","author":"Hussain","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.1011560108","article-title":"Validation of isoleucine utilization targets in Plasmodium falciparum","volume":"108","author":"Istvan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2017.07.015_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pt.2011.05.005","article-title":"Protein translation in Plasmodium parasites","volume":"27","author":"Jackson","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10969-014-9186-x","article-title":"Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase","volume":"15","author":"Jain","year":"2014","journal-title":"J.\u00a0Struct. Funct. Genomics"},{"key":"10.1016\/j.str.2017.07.015_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pt.2016.12.007","article-title":"Repurposing of potent drug candidates for multiparasite targeting","volume":"33","author":"Jain","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsinfecdis.6b00181","article-title":"Structure-based targeting of orthologous pathogen proteins accelerates antiparasitic drug discovery","volume":"3","author":"Jain","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.str.2017.07.015_bib21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.str.2015.02.011","article-title":"Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis","volume":"23","author":"Jain","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.str.2017.07.015_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature19804","article-title":"Diversity-oriented\u00a0synthesis yields novel multistage antimalarial inhibitors","volume":"538","author":"Kato","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.str.2017.07.015_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1107\/S0907444913001923","article-title":"Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development","volume":"69","author":"Khan","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib24","doi-asserted-by":"crossref","first-page":"e66224","DOI":"10.1371\/journal.pone.0066224","article-title":"An appended domain results in an unusual architecture for malaria parasite tryptophanyl-tRNA synthetase","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2017.07.015_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10969-014-9182-1","article-title":"Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin","volume":"15","author":"Khan","year":"2014","journal-title":"J.\u00a0Struct. Funct. Genomics"},{"key":"10.1016\/j.str.2017.07.015_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/srep00188","article-title":"Uneven spread of cis- and trans-editing aminoacyl-tRNA synthetase domains within translational compartments of P.\u00a0falciparum","volume":"1","author":"Khan","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.str.2017.07.015_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.str.2017.07.015_bib28","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1021\/jm0601809","article-title":"Exploration of a new type of antimalarial compounds based on febrifugine","volume":"49","author":"Kikuchi","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.str.2017.07.015_bib29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.str.2012.07.011","article-title":"Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection","volume":"20","author":"Koh","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.str.2017.07.015_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib31","doi-asserted-by":"crossref","first-page":"e0003889","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in\u00a0vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.str.2017.07.015_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.str.2017.07.015_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib34","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib35","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/AAC.00873-16","article-title":"Cryptosporidium and toxoplasma parasites are inhibited by a benzoxaborole targeting leucyl-tRNA synthetase","volume":"60","author":"Palencia","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00034983.1975.11686997","article-title":"The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P.\u00a0berghei in screening for blood schizontocidal activity","volume":"69","author":"Peters","year":"1975","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib37","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.str.2017.07.015_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2013.10.001","article-title":"Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites","volume":"4","author":"Pham","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.str.2017.07.015_bib39","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site","volume":"316","author":"Rock","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.str.2017.07.015_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1054-3589(08)60459-7","article-title":"Chemotherapy of chicken coccidiosis","volume":"11","author":"Ryley","year":"1973","journal-title":"Adv. Pharmacol. Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmb.2009.04.073","article-title":"Crystal structures of the human and fungal cytosolic leucyl-tRNA synthetase editing domains: a structural basis for the rational design of antifungal benzoxaboroles","volume":"390","author":"Seiradake","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.str.2017.07.015_bib41","doi-asserted-by":"crossref","first-page":"e0005084","DOI":"10.1371\/journal.pntd.0005084","article-title":"Protein translation enzyme lysyl-tRNA synthetase presents a new target for drug development against causative agents of loiasis and schistosomiasis","volume":"10","author":"Sharma","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.str.2017.07.015_bib42","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib43","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1128\/AAC.00820-16","article-title":"Antimalarial benzoxaboroles target\u00a0Plasmodium falciparum leucyl-tRNA synthetase","volume":"60","author":"Sonoiki","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2017.07.015_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molbiopara.2004.05.009","article-title":"Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method","volume":"137","author":"Tonkin","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1645\/0022-3395(2005)091[0484:HMPICC]2.0.CO;2","article-title":"Human malaria parasites in continuous culture. 1976","volume":"91","author":"Trager","year":"2005","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.str.2017.07.015_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1286-4579(02)01629-5","article-title":"Cryptosporidiosis: biology, pathogenesis and disease","volume":"4","author":"Tzipori","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.str.2017.07.015_bib48","series-title":"WHO malaria report, 2015","author":"WHO","year":"2015"},{"key":"10.1016\/j.str.2017.07.015_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D\u00a0Biol. Crystallogr."},{"key":"10.1016\/j.str.2017.07.015_bib50","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1016\/j.bmc.2009.05.011","article-title":"Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg. Med. Chem."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212617302496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212617302496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T20:22:22Z","timestamp":1538511742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212617302496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0969212617302496"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2017.07.015","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}